Lariam Articles
Positive clinical trials on new anti-malarial developed by Sigma-Tau
28 September 2009
Sosei out-licenses mefloquine to Treague
1 December 2008
DNDi in "patent-free" antimalarial drug deal
5 May 2008
Danger to patients from weak US Rx system: CU
12 December 2005
WHO urges responsible use of antimalarials
12 September 2005
Barr receives approval for generic Larium
5 January 2004
UK Industry Code of Practice: latest Report
4 March 1996
Roche Sued Over Lariam Side Effects
12 February 1996
EIRE POM TO P SWITCH
15 March 1993
DRUG COMPANIES FAILING TO TARGET MALARIA?
9 November 1992
Showing 1-12 of 12 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
